Yüklüyor......
Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment
Repurposing of approved antiviral drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a promising strategy to treat Coronavirus disease 2019 (COVID-19) patients. Previously we reported our hypothesis that the antiviral drugs with high lung distributions might benefit COVID-...
Kaydedildi:
| Yayımlandı: | Eur J Pharmacol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier B.V.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7536545/ https://ncbi.nlm.nih.gov/pubmed/33031797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173634 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|